- Tytuł:
- Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
- Autorzy:
- Źródło:
- The Lancet; December 2021, Vol. 398 Issue: 10317 p2173-2184, 12p
Periodyk